Clinical Study on Efficacy and Safety of Insufflation with Unani Formulation in The Management of Otomycosis.
Phase 2
- Conditions
- Health Condition 1: H619- Disorder of external ear, unspecified
- Registration Number
- CTRI/2024/03/064699
- Lead Sponsor
- Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Clinically diagnosed patient of Otomycosis
2.All gender are included
Exclusion Criteria
1.Patients with any serious debilitating diseases like malignancies, tuberculosis, and other chronic granulomatous diseases.
2.Patients with immune-compromised conditions and history suggestive of fungal diseases elsewhere in the body and those on topical antifungal drops will be excluded from the study.
3.Patient suffering from any other aural pathology e.g. Chronic Suppurative Otitis Media (CSOM), Acute Suppurative Otitis Media (ASOM), Perforation of tympanic membrane, etc. will be excluded from
the study.
4.Patient who refused to give their consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Clinical sign and symptoms <br/ ><br>2.Clinical examinationTimepoint: baseline, 5th, 10th, 15th day
- Secondary Outcome Measures
Name Time Method 1.Post treatment examination (Smear examination by 10%KOH preparation of ear & Fungal culture of ear will be done on 30th day.Timepoint: 30th day